2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Pharmacology

Acute Kidney Dysfunction in Cirrhosis: Diagnosis, Drugs, and Dialysis

Bridge to Nowhere? Key Considerations With Dialysis in Cirrhosis

Sunday, March 22, 2026
12:20 PM - 12:35 PM Central Time

  • Kathleen Liu, MD, PhD,

    University of California San Francisco Medical Center, California

    Disclosure(s): 3M: Major Stockholder (not including mutual funds) (Ongoing); AM Pharma: Consultant (Terminated, September 30, 2023); Amgen: Major Stockholder (not including mutual funds) (Ongoing); Atom: Consultant (Terminated, July 31, 2025); Biomerieux: Consultant (Terminated, November 1, 2023); InflaRx Pharmaceuticals: Advisory Board (Terminated, August 31, 2024); Lightening Health: Advisory Board (Terminated, August 31, 2024); Novartis: Advisory Board (Ongoing); Regeneron: Advisory Board (Ongoing); Seastar Medical: Advisory Board (Ongoing); UptoDate: Receipt of Royalties (Ongoing)